Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/1996
12/03/1996US5580767 Some of internucleotide linkages within oligonucleotide are phosphorothioate linkages
12/03/1996US5580760 FUSE binding protein and cDNA therefor
12/03/1996US5580757 Culturing mammalian cell transformed with recombinant vector including nucleotide sequence encoding cleavage site sandwiched between galactosidase and protein a coding sequences, recovering expressed fusion protein, cleaving
12/03/1996US5580756 Ligand which is reactive with the cd28 receptor on t cells
12/03/1996US5580755 Human pluripotent granulocyte colony-stimulating factor
12/03/1996US5580754 Culturing; transformation; transfection; isolation
12/03/1996US5580753 DNA encoding the human cytokine, interleukin-9
12/03/1996US5580740 Antihuman pulmonary adenocarcinoma monoclonal antibody
12/03/1996US5580739 Peptides of human immunodeficiency virus type 2 (HIV-2) and in vitro diagnostic methods and kits employing the peptides for the detection of HIV-2
12/03/1996US5580738 Delta-like gene expressed in neuroendocrine tumors
12/03/1996US5580736 Having a cell with a reporter gene linked to a dna sequence comprising a protein binding site, a first and second fusiongene; interacting the binding proteins expressed; measuringthe expression of the reporter gene
12/03/1996US5580723 Comparing the activities of a segment-substituted polypeptide and the parent polypeptide; borrowing receptor binding properties from functionally divergent hormones
12/03/1996US5580722 Methods of determining chemicals that modulate transcriptionally expression of genes associated with cardiovascular disease
12/03/1996US5580716 Parasite-derived resistance
12/03/1996US5580570 Pharmaceutical compositions and methods of treatment of the cornea following laser irradiation
12/03/1996US5580561 Methods and pharmaceutical compositions for blocking suppression of immune defense mechanisms using an antibody, a factor, or an antisense peptide
12/03/1996US5580560 Modified factor VII/VIIa
12/03/1996US5580558 Delivery of gene products via mesangial cells
12/03/1996US5580556 Pharmaceutical compositions containing interferons and fatty acids
12/03/1996US5580555 Administering tumor necrosis factor and irradiating with low energy laser
12/03/1996US5580554 Methods of treating preeclampsia
12/03/1996CA2075833C Neuropeptide control of ocular growth
12/03/1996CA2036997C Leu3a binding peptides
12/03/1996CA2028140C Novel bacteriocin compositions for use as enhanced broad range
12/02/1996CA2177509A1 Antisense strategy for viral insecticides
11/1996
11/28/1996WO1996037776A1 Functional ligands for the axonal cell recognition molecule contactin
11/28/1996WO1996037775A1 Methods for g protein coupled receptor activity screening
11/28/1996WO1996037626A1 Position-specific integration of vector constructs into eukaryotic genomes mediated by a chimeric integrase protein
11/28/1996WO1996037621A2 Multimeric proteins
11/28/1996WO1996037619A1 Method for reproducing in vitro the rna-dependent rna polymerase and terminal nucleotidyl transferase activities encoded by hepatitis c virus (hcv)
11/28/1996WO1996037611A1 Eb1 gene product binds to apc
11/28/1996WO1996037610A2 Cck-4, a receptor tyrosine kinase, and methods for diagnosis and treatment of cck-4 signal transduction disorders
11/28/1996WO1996037609A1 A gene switch comprising an ecdysone receptor
11/28/1996WO1996037608A1 Novel variants of apolipoprotein a-i
11/28/1996WO1996037607A2 Nucleic acid with a polymorphic domain of a b2 bradykinin receptor gene
11/28/1996WO1996037517A1 Rhesus ob protein and dna
11/28/1996WO1996037514A1 Chimeric fatty body-pro-grf analogs with increased biological potency
11/28/1996WO1996037513A1 cDNA CLONES ENCODING HUMAN G PROTEIN η SUBUNITS
11/28/1996WO1996037512A1 Cyclic peptide antifungal agents
11/28/1996WO1996037511A1 Cyclic peptides antifungal agents
11/28/1996WO1996037510A1 Cyclic peptide antifungal agents
11/28/1996WO1996037509A1 Cyclic peptide antifungal agents
11/28/1996WO1996037508A1 Protegrins
11/28/1996WO1996037239A1 Peptide radiopharmaceutical applications
11/28/1996WO1996037235A1 Methods for inhibition of hiv
11/28/1996WO1996037234A1 Intracellular immunization
11/28/1996WO1996037233A1 Polymyxin conjugates
11/28/1996WO1996037228A1 Antibacterial-wound healing compositions and methods for preparing and using same
11/28/1996WO1996037225A1 Method for treatment of sle
11/28/1996WO1996037224A1 Methods of treating colon cancer utilizing tumor-specific antibodies
11/28/1996WO1996037223A1 Muscle trophic factor
11/28/1996WO1996037218A1 Parasitic helminth venom allergen antigen 5-like genes and proteins
11/28/1996WO1996037217A1 Clinical disorders associated with carboxypeptidase e mutation
11/28/1996WO1996037216A1 Method of administration of igf-i
11/28/1996WO1996037215A1 Oral insulin delivery
11/28/1996WO1996037214A2 Compositions of interleukin and pyrimidine nucleosides
11/28/1996WO1996037213A1 The use of des-aspartate-angiotensin i as an anti-cardiac hypertrophic agent
11/28/1996WO1996037212A1 POLYPEPTIDE COMPOUNDS THAT FORM β SHEETS
11/28/1996WO1996037208A1 Allogeneic cell therapy for cancer following allogeneic stem cell transplantation
11/28/1996WO1996037196A1 Oral dosage composition for intestinal delivery and method of use of the same
11/28/1996WO1996037107A1 Antigen-specific activation of unprimed cd8+ t cells
11/28/1996WO1996037104A1 Compositions and methods for inhibiting fibrogenesis
11/28/1996WO1996033277A3 Recombinant preduodenal lipases and polypeptide derivatives produced by plants, processes for obtaining them and their uses
11/28/1996WO1996029406A3 Nuclear localization factor associated with circadian rhythms
11/28/1996WO1996029405A3 Modulators of ob gene and screening methods therefor
11/28/1996WO1996029065A3 Aminotetralin derivative for the therapy of cardiovascular diseases
11/28/1996WO1996023883A3 Modified ligands for receptor tyrosine kinases
11/28/1996WO1996021734A3 P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods
11/28/1996CA2222475A1 Protegrins
11/28/1996CA2222055A1 Multimeric proteins
11/28/1996CA2222018A1 Oral dosage composition for intestinal delivery and method of use of the same
11/28/1996CA2221935A1 Method of treating colon cancer utilizing tumor-specific antibodies
11/28/1996CA2221824A1 Rhesus ob protein and dna
11/28/1996CA2221818A1 Parasitic helminth venom allergen antigen 5-like genes and proteins
11/28/1996CA2221783A1 Cdna clones encoding human g protein .gamma. subunits
11/28/1996CA2221159A1 Eb1 gene product binds to apc
11/28/1996CA2220971A1 Allogeneic cell therapy for cancer following allogeneic stem cell transplantation
11/28/1996CA2220944A1 Cyclic peptide antifungal agents
11/28/1996CA2220837A1 Compositions of interleukin and pyrimidine nucleosides
11/28/1996CA2220728A1 Cyclic peptide antifungal agents
11/28/1996CA2220688A1 Cyclic peptide antifungal agents
11/28/1996CA2219778A1 Polymyxin conjugates
11/28/1996CA2219492A1 Peptide radiopharmaceutical applications
11/28/1996CA2219121A1 A gene switch comprising an ecdysone receptor
11/28/1996CA2218759A1 Novel variants of apolipoprotein a-i
11/28/1996CA2218726A1 Methods for g protein coupled receptor activity screening
11/28/1996CA2218018A1 Method of administration of igf-i
11/27/1996EP0744409A1 Platelet growth accelerator
11/27/1996EP0744408A2 Rhesus ob protein and DNA
11/27/1996EP0744407A2 Cyclic peptide antifungal agents
11/27/1996EP0744406A2 Cyclic peptide antifungal agents
11/27/1996EP0744405A2 Cyclic peptide antifungal agents
11/27/1996EP0744404A2 Cyclic peptide antifungal agents
11/27/1996EP0744027A1 Hydrophilic signal oligopeptides and methods of therapeutic use
11/27/1996EP0743984A1 Nucleic acid-containing composition, its preparation and use
11/27/1996EP0743958A1 Non-viral vector
11/27/1996EP0743956A1 Pretargeting methods and compounds
11/27/1996EP0743955A1 Nerve growth factor structural analogs and their uses
11/27/1996EP0743954A1 Methods for variation of chromatin condensation
11/27/1996EP0743953A1 Diastereomeric pure trifluoromethyl ketone peptide derivatives as inhibitors of human leukocyte elastase
1 ... 2752 2753 2754 2755 2756 2757 2758 2759 2760 2761 2762 2763 2764 2765 2766 2767 2768 2769 2770 2771 2772 ... 3163